MeiraGTx Holdings plc 328.F Stock
MeiraGTx Holdings plc Price Chart
MeiraGTx Holdings plc 328.F Financial and Trading Overview
| MeiraGTx Holdings plc stock price | 5 EUR |
| Previous Close | 6.75 EUR |
| Open | 6.9 EUR |
| Bid | 6.9 EUR x N/A |
| Ask | 7.5 EUR x N/A |
| Day's Range | 6.9 - 6.9 EUR |
| 52 Week Range | 4.38 - 10.7 EUR |
| Volume | 8 EUR |
| Avg. Volume | 13 EUR |
| Market Cap | 432.44M EUR |
| Beta (5Y Monthly) | 1.370844 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.09 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
328.F Valuation Measures
| Enterprise Value | 424.62M EUR |
| Trailing P/E | N/A |
| Forward P/E | -3.556701 |
| PEG Ratio (5 yr expected) | -2.61 |
| Price/Sales (ttm) | 31.7478 |
| Price/Book (mrq) | 3.7236912 |
| Enterprise Value/Revenue | 31.174 |
| Enterprise Value/EBITDA | -3.871 |
Trading Information
MeiraGTx Holdings plc Stock Price History
| Beta (5Y Monthly) | 1.370844 |
| 52-Week Change | 11.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.7 EUR |
| 52 Week Low | 4.38 EUR |
| 50-Day Moving Average | 5.42 EUR |
| 200-Day Moving Average | 6.45 EUR |
328.F Share Statistics
| Avg. Volume (3 month) | 13 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 59.5M |
| Float | 31.37M |
| Short Ratio | N/A |
| % Held by Insiders | 10.04% |
| % Held by Institutions | 61.46% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -876.44% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.91% |
| Return on Equity (ttm) | -102.52% |
Income Statement
| Revenue (ttm) | 13.62M EUR |
| Revenue Per Share (ttm) | 0.3 EUR |
| Quarterly Revenue Growth (yoy) | -40.79% |
| Gross Profit (ttm) | 15.92M EUR |
| EBITDA | -109684000 EUR |
| Net Income Avi to Common (ttm) | -128934000 EUR |
| Diluted EPS (ttm) | -2.67 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 68.78M EUR |
| Total Cash Per Share (mrq) | 1.16 EUR |
| Total Debt (mrq) | 91.77M EUR |
| Total Debt/Equity (mrq) | 101.72 EUR |
| Current Ratio (mrq) | 1.498 |
| Book Value Per Share (mrq) | 1.853 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -102192000 EUR |
| Levered Free Cash Flow (ttm) | -62528752 EUR |
Profile of MeiraGTx Holdings plc
| Country | Germany |
| State | NY |
| City | New York |
| Address | 450 East 29th Street |
| ZIP | 10016 |
| Phone | 646 860 7985 |
| Website | https://meiragtx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 343 |
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.
Q&A For MeiraGTx Holdings plc Stock
What is a current 328.F stock price?
MeiraGTx Holdings plc 328.F stock price today per share is 5 EUR.
How to purchase MeiraGTx Holdings plc stock?
You can buy 328.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MeiraGTx Holdings plc?
The stock symbol or ticker of MeiraGTx Holdings plc is 328.F.
Which industry does the MeiraGTx Holdings plc company belong to?
The MeiraGTx Holdings plc industry is Biotechnology.
How many shares does MeiraGTx Holdings plc have in circulation?
The max supply of MeiraGTx Holdings plc shares is 64.31M.
What is MeiraGTx Holdings plc Price to Earnings Ratio (PE Ratio)?
MeiraGTx Holdings plc PE Ratio is now.
What was MeiraGTx Holdings plc earnings per share over the trailing 12 months (TTM)?
MeiraGTx Holdings plc EPS is -1.09 EUR over the trailing 12 months.
Which sector does the MeiraGTx Holdings plc company belong to?
The MeiraGTx Holdings plc sector is Healthcare.